Application specialists from Tecan have teamed up with Technoclone Vienna, and the University Children’s Hospital in Zurich to validate the TECHNOTHROMBIN thrombin generation assay (TGA) for Tecan’s Infinite M200 multimode microplate reader. Dr Oliver Speer, head of the Experimental Hematology and Erythrocyte Laboratory at the hospital, explained: “We installed the Infinite reader in our laboratory to standardise all of our photometric assays using just a single platform. Once we had completed the transfer of our existing assays to the Infinite, we realised that the flexibility and sensitivity of the instrument would allow us to supersede some of these assays with more efficient or sensitive methods, so became interested in the TECHNOTHROMBIN TGA.”
Polls
Loading ...